News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lawton Alison Frances
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
4
| Lawton Alison Frances (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 1,950,000 options to buy
@ $0.3, valued at
$585k
|
|
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Lawton Alison Frances (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.8, valued at
$272k
|
|
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| Lawton Alison Frances (Director) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 36,377 options to buy
@ $7.85, valued at
$285.6k
|
|
| 12/17/2020 |
4
| Lawton Alison Frances (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 47,200 options to buy
@ $9.09, valued at
$429k
|
|
| 10/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2020 |
4
| Lawton Alison Frances (See Remarks) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 118,500 options to buy
@ $6, valued at
$711k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2019 |
4
| Lawton Alison Frances (See Remarks) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 150,000 options to buy
@ $6.56, valued at
$984k
|
|
| 06/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/15/2016 |
4
| Lawton Alison Frances (Director) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Granted 1,420 options to buy
@ $6.54, valued at
$9.3k
|
|
| 06/11/2013 |
4
| Lawton Alison Frances (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Exercised 1,347 restricted stock units
@ $0 |
|
| 06/11/2013 |
4
| Lawton Alison Frances (COO) has filed a Form 4 on OvaScience, Inc. |
| 06/06/2013 |
4
| LAWTON ALISON FRANCIS (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 12,500 options to buy
@ $9.34, valued at
$116.8k
Granted 6,507 options to buy
@ $9.34, valued at
$60.8k
|
|
| 03/11/2013 |
4
| LAWTON ALISON FRANCIS (COO) has filed a Form 4 on OvaScience, Inc. |
| 11/27/2012 |
4
| LAWTON ALISON FRANCIS (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 25,000 options to buy
@ $6.47, valued at
$161.8k
|
|
| 06/11/2012 |
4
| LAWTON ALISON FRANCIS (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Granted 372 shares
@ $0
Granted 9,367 options to buy
@ $41.2, valued at
$385.9k
Granted 1,347 restricted stock units
@ $0 |
|
| 02/17/2012 |
4
| LAWTON ALISON FRANCIS (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Granted 10,842 options to buy
@ $40.59, valued at
$440.1k
|
|
|
|